DE69804169D1 - Oral anzuwendende flüssige Arzneilösung - Google Patents
Oral anzuwendende flüssige ArzneilösungInfo
- Publication number
- DE69804169D1 DE69804169D1 DE69804169T DE69804169T DE69804169D1 DE 69804169 D1 DE69804169 D1 DE 69804169D1 DE 69804169 T DE69804169 T DE 69804169T DE 69804169 T DE69804169 T DE 69804169T DE 69804169 D1 DE69804169 D1 DE 69804169D1
- Authority
- DE
- Germany
- Prior art keywords
- oral liquid
- medicinal solution
- liquid medicinal
- weight
- volume
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97201964 | 1997-06-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69804169D1 true DE69804169D1 (de) | 2002-04-18 |
DE69804169T2 DE69804169T2 (de) | 2002-08-29 |
Family
ID=8228492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69804169T Expired - Lifetime DE69804169T2 (de) | 1997-06-27 | 1998-06-23 | Oral anzuwendende flüssige Arzneilösung |
Country Status (8)
Country | Link |
---|---|
US (1) | US6127425A (de) |
EP (1) | EP0893121B1 (de) |
JP (1) | JPH1171269A (de) |
AT (1) | ATE214269T1 (de) |
DE (1) | DE69804169T2 (de) |
DK (1) | DK0893121T3 (de) |
ES (1) | ES2174388T3 (de) |
PT (1) | PT893121E (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6136799A (en) * | 1998-04-08 | 2000-10-24 | Abbott Laboratories | Cosolvent formulations |
FI109332B (fi) | 1998-12-17 | 2002-07-15 | Orion Yhtymae Oyj | Toremifeenin liukoisia koostumuksia |
FI982733A (fi) | 1998-12-17 | 2000-06-18 | Orion Yhtymae Oyj | Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia |
US6541367B1 (en) * | 2000-01-18 | 2003-04-01 | Applied Materials, Inc. | Very low dielectric constant plasma-enhanced CVD films |
FR2910317B1 (fr) * | 2006-12-21 | 2009-02-13 | Philippe Perovitch | Forme galenique pour l'administration par voie transmuqueuse de paracetamol |
KR101025498B1 (ko) * | 2008-05-02 | 2011-03-31 | (주)이엘티사이언스 | 염산브롬헥신 경구용 액제 복합조성물 및 그 제조방법 |
WO2012142029A2 (en) | 2011-04-10 | 2012-10-18 | Florida A&M University | Serms for the treatment of estrogen receptor-mediated disorders |
ITUA20162292A1 (it) * | 2016-04-05 | 2017-10-05 | Gb Pharma S R L | Uso del tamoxifene per il trattamento della fibrosi cistica in pazienti di entrambi i sessi |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE293263C (de) * | ||||
WO1984001506A1 (en) * | 1982-10-13 | 1984-04-26 | Univ Birmingham | Pharmaceutical preparations for use in antitumour therapy |
GB8604528D0 (en) * | 1986-02-24 | 1986-04-03 | Ici Plc | Therapeutic agents |
DD293263A5 (de) * | 1990-03-23 | 1991-08-29 | Adw,Zi Fuer Molekularbiologie,De | Mittel zur hemmung des tumorwachstums |
GB9126209D0 (en) * | 1991-12-10 | 1992-02-12 | Orion Yhtymae Oy | Drug formulations for parenteral use |
IT1263831B (it) * | 1993-01-29 | 1996-09-04 | Paolo Chiesi | Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina |
DE4335876A1 (de) * | 1993-10-17 | 1995-04-20 | Schering Ag | Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen |
US5683993A (en) * | 1995-06-22 | 1997-11-04 | Ciba Vision Corporation | Compositions and methods for stabilizing polymers |
TW389694B (en) * | 1995-08-17 | 2000-05-11 | Novartis Ag | Compositions including o-carboxyalkyl chitosan and methods of use in ophthalmics |
-
1998
- 1998-06-23 EP EP98202077A patent/EP0893121B1/de not_active Expired - Lifetime
- 1998-06-23 DE DE69804169T patent/DE69804169T2/de not_active Expired - Lifetime
- 1998-06-23 ES ES98202077T patent/ES2174388T3/es not_active Expired - Lifetime
- 1998-06-23 AT AT98202077T patent/ATE214269T1/de active
- 1998-06-23 PT PT98202077T patent/PT893121E/pt unknown
- 1998-06-23 DK DK98202077T patent/DK0893121T3/da active
- 1998-06-24 JP JP10176890A patent/JPH1171269A/ja not_active Withdrawn
- 1998-06-26 US US09/106,172 patent/US6127425A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69804169T2 (de) | 2002-08-29 |
PT893121E (pt) | 2002-06-28 |
US6127425A (en) | 2000-10-03 |
EP0893121B1 (de) | 2002-03-13 |
ES2174388T3 (es) | 2002-11-01 |
DK0893121T3 (da) | 2002-06-17 |
EP0893121A1 (de) | 1999-01-27 |
ATE214269T1 (de) | 2002-03-15 |
JPH1171269A (ja) | 1999-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8505112D0 (sv) | Novel pharmacological compounds | |
EA200500891A1 (ru) | Фармацевтические композиции, содержащие щелочные или соответственно кислые лекарственные соединения, поверхностно-активное вещество и физиологически приемлемую водорастворимую кислоту или соответственно основание | |
NO870241L (no) | Hypoglykemiske tiazolidindioner. | |
EA200200431A1 (ru) | Фармацевтические композиции, обеспечивающие повышенные концентрации лекарства | |
SE8402551L (sv) | Cinnamoylmoranolin-derivat | |
ATE64306T1 (de) | Mittel zur erhoehung der transdermalen permeation. | |
KR890016966A (ko) | 신규 항바이러스제 | |
KR890700125A (ko) | 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물 | |
HUT67661A (en) | New pyrazine derivatives, their preparation and pharmaceutical compositions containing them | |
DE69804169D1 (de) | Oral anzuwendende flüssige Arzneilösung | |
HUP0402549A2 (hu) | Parenterális paracetamol készítmény | |
KR880007060A (ko) | 제약 조성물 | |
DE69531736D1 (de) | Oxytetracyclin enthaltendes arzneimittel mit verzögerter wirksoffabgabe | |
ATE444739T1 (de) | Polymerzusammensetzung sowie diese enthaltende darreichungsformen | |
JPS5781409A (en) | External plaster | |
KR830004849A (ko) | 약학적 제제의 제조방법 | |
IT1187743B (it) | Composizioni farmaceutiche a base di destrorfano per applicazione instranasale | |
JPS5762221A (en) | Embrocation for external use | |
KR920019349A (ko) | 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도 | |
JPS5762220A (en) | Embrocation for external use | |
SE8104675L (sv) | Farmacevtisk komposition med antiflogistisk, antipyretisk och analgetisk verkan | |
JPS57206609A (en) | Solution for external use | |
JPS56161324A (en) | Anti-inflammatory and pain-killing gel | |
JPS5688758A (en) | Chewing gum containing dextranase and its production | |
JPS54105237A (en) | Analgesic agent containing nalorphine-6-glucuronide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: SAVIENT PHARMACEUTICALS, INC., EAST BRUNSWICK, N.J |
|
8327 | Change in the person/name/address of the patent owner |
Owner name: SAVIENT PHARMA HOLDINGS,INC., WILMINGTON, DEL., US |
|
8327 | Change in the person/name/address of the patent owner |
Owner name: ROSEMONT GROUP LTD., LEEDS, GB |